Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy People to Test How Vicadrostat Affects the Heart
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to investigate the effect of vicadrostat on the heart compared with placebo in healthy male and female volunteers.
Official title: Thorough QT Study to Evaluate the Effects of Single Doses of Vicadrostat on Cardiac Safety Parameters in Healthy Male and Female Subjects (a Randomized, Placebo-controlled, Double-blind, Five-period Crossover Study With Open-label Moxifloxacin as Positive Control)
Key Details
Gender
All
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
45
Start Date
2026-04-22
Completion Date
2026-08-21
Last Updated
2026-04-07
Healthy Volunteers
Yes
Conditions
Interventions
Vicadrostat
Vicadrostat
Placebo matching Vicadrostat
Placebo matching Vicadrostat
Moxifloxacin
Moxifloxacin
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany